GlassScriptPhysician profile
Michael G Petersen
NPI 1972746931
$11,395.66
in general payments reported to CMS, 2019-2025
51 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,136 · 2022: $2,487 · 2023: $2,329 · 2024: $2,796 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,747 · Education: $26.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,746.59 |
| Education | $26.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,474.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,236.22 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,176.77 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $915.89 | 2021-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $867.06 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $425.34 | 2021-2025 | |
| Pfizer INC. | $354.86 | 2021-2025 | |
| Amgen INC. | $336.16 | 2021-2025 | Otezla, Repatha, Evenity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.85 | 2021-2025 | Xifaxan |
| Astellas Pharma US INC | $239.14 | 2021-2024 | Veozah |
| Teva Pharmaceuticals USA, INC. | $226.79 | 2022-2024 | Austedo Xr, Austedo |
| Eisai INC. | $207.68 | 2021 | |
| Lundbeck LLC | $207.51 | 2023-2024 | Vyepti |
| Bayer Healthcare Pharmaceuticals INC. | $201.45 | 2022-2025 | |
| Exact Sciences Corporation | $181.40 | 2023-2025 | Cologuard Collection Kit |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.